SCHEMBL15066637

SCHEMBL15066637

CN(C)C=CC(=O)c1cc2ccc(N3CCN(C(=O)O)CC3)cc2oc1=O

nearest known ligand 0.58

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ SLC16A3 O15427 2/20 0.56
▸ MAPT P10636 3/20 0.46
▸ ALDH1A1 P00352 4/20 0.45
▸ APP P05067 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ BCHE P06276 1/20 0.42
▸ RAB9A P51151 2/20 0.41
▸ HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16674796 0.88 SLC16A3 (0.56) SLC16A3MAPTALDH1A1APPKDM4E
SCHEMBL15066750 0.86 MAOB (0.49) SLC16A3MAPTALDH1A1KDM4ELMNA
SCHEMBL15086510 0.86 MAOB (0.49) SLC16A3MAPTALDH1A1KDM4ELMNA
SCHEMBL28868213 0.83 SLC16A3 (0.52) SLC16A3MAPTALDH1A1APPKDM4E
SCHEMBL15065820 0.79 SLC16A3 (0.57) SLC16A3MAPTALDH1A1APPKDM4E
SCHEMBL16669729 0.79 SLC16A3 (0.57) SLC16A3MAPTALDH1A1APPKDM4E
SCHEMBL4505056 0.76 SLC16A3 (0.75) SLC16A3MAPTALDH1A1APPKDM4E
SCHEMBL18493220 0.74 SLC16A3 (0.81) SLC16A3ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL15138692 0.74 SLC16A3 (0.81) SLC16A3ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL16312889 0.73 SLC16A3 (0.70) SLC16A3MAPTALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2797592-A1 COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY PTC Therapeutics, Inc. (US) 2014-11-05 — — EP disclosed
WO-2013101974-A1 COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY PTC THERAPEUTICS, INC. (US) 2013-07-04 — — WO disclosed
Send feedback